Track the 株式会社ジンズホールディングス stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are quoted on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社ジンズホールディングス has published 3 reports. Market capitalisation: €134.7bn. The latest transaction was filed on 25 September 2026 (Holding update). Among the most active insiders: Taiyo Pacific Partners L.P.. The full history is openly available.
Analysts rate 株式会社ジンズホールディングス Buy (bullish), based on 7 analysts. Average price target: JP¥7,800.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
JINS Holdings Inc. is a Japanese company specializing in health and pharmaceuticals. It is listed on the XTKS market.
Purchases our model currently ranks for the recommendations list.
All recommendations